Analyzing the Growth of Pharmacological Chaperone Therapy: Meeting the Demand for Stabilizing Mutant Glucocerebrosidase Enzymes (2025–2032)
The global Gaucher Disease Market is a specialized yet high-value segment of the orphan drug industry. Gaucher disease is a rare, autosomal recessive genetic disorder caused by a deficiency in the enzyme glucocerebrosidase. This deficiency leads to the harmful accumulation of fatty substances (glucocerebrosides) in the liver, spleen, bone marrow, and sometimes the nervous...
0 Kommentare 0 Geteilt 8 Ansichten 0 Bewertungen
Lifesone https://lifesone.com